Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working groupCarsten Denkert, Roberto Salgado, Stephan Wienert et al.|Modern Pathology|2016Cited by 281
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)Meenakshi Anurag, Matthew J. Ellis, Vera J. Suman et al.|JNCI Journal of the National Cancer Institute|2019Cited by 73
Response: Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerTorsten O. Nielsen, Matthew J. Ellis, Maggie C.U. Cheang et al.|JNCI Journal of the National Cancer Institute|2009Cited by 32
Preclinical Efficacy and Safety Assessment of an Antibody–Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast CarcinomaMinh Nguyen, Andrew D. Simmons, Shuichi Miyakawa et al.|Clinical Cancer Research|2015Cited by 26